The initial public offering (IPO) market is red hot in the week ahead with 10 traditional IPOs planning to raise nearly $4.3 billion in their debuts.

For the largest offering of the week, UiPath, Inc. (PATH  ) plans to raise nearly $1.5 billion from roughly 24 million shares priced in the range of $52 to $54 each. The AI provider offers software that identifies areas of operations where companies can automate.

Agiliti, Inc. (AGTI  ) plans to raise more than $605 million from over 26 million shares priced between $18 to $20 each. The medical device management company provides services and solutions to around 7,000 hospitals in the United States.

Zymergen, Inc. (ZY  ) plans to raise nearly $485 million from 13.6 million shares priced in the range of $28 to $31 each. The synthetic biology company is focused on the design, discovery, and development of biologically and chemically-based innovations for a broad array of industries.

Latham Group, Inc. (SWIM  ) plans to raise $483 million from 20 million shares priced between $19 to $21 each. The swimming pool company is the largest designer, manufacturer, and marketer of in-ground residential swimming pools in North America, Australia, and New Zealand. Latham is set to benefit from the consumer trends towards single-family homes in response to the pandemic.

DoubleVerify Holdings, Inc. (DV  ) plans to raise over $414 million from more than 13.3 million shares priced between $24 to $27 each. The advertising analytics platform provides a suite of tools that enable advertisers to assess how effective their ads are at targeting their audience.

KnowBe4, Inc. (KNBE  ) plans to raise nearly $245 million from about 12 million shares priced between $16 to $18 each. The cybersecurity company provides programs to train and educate employees to recognize cybersecurity attacks.

Treace Medical Concepts, Inc. (TMCI  ) plans to raise over $183 million from about 9.4 million shares priced between $15 to $17 each. The medical device maker's proprietary device is the Lapiplasty 3D Bunion Correction System, with the company also providing other novel instruments, implants, and surgical methods for bunion surgery.

Rain Therapeutics, Inc. (RAIN  ) plans to raise over $152 million from about 7.4 million shares priced between $16 to $18 each. The oncology-focused biotech expects to begin a Phase 3 clinical trial in liposarcoma in the 2H21, a Phase 2 tumor-agnostic basket trial in certain solid tumors in the 2H21, and a Phase 2 trial in intimal sarcoma by early 2022.

NeuroPace, Inc. (NPCE  ) plans to raise about $104 million from more than 5.3 million shares priced between $15 to $17 each. The epilepsy medical device developer's RNS System is the first and only commercially available neuromodulation system for treatment at the source of seizures.

SkyWater Technology, Inc. (SKYT  ) plans to raise more than $93 million from 5.8 million shares priced between $12 to $14 each. The semiconductor manufacturer is developing disruptive design concepts for integrated circuit boards and other micro- and nanotechnology through its Advanced Technology services.